Nutrition Health Research Center, School of Medicine, Lorestan University of Medical Sciences, Khoramabad, Iran.
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khoramabad, Iran.
BMC Womens Health. 2024 Sep 27;24(1):540. doi: 10.1186/s12905-024-03378-4.
Breast cancer is one of the most common cancers in women worldwide. This study aims is to investigate the burden of breast cancer in Iran and its relationship with the Human Development Index (HDI) during 2009 to 2019.
The present study is an observational study in Iran during the years 2009 to 2019. Data related to the incidence, mortality, Years of Life with Disability (YLD), Years of Life Lost (YLL) and Disability-Adjusted Life-Years (DALY) of breast cancer in Iran were extracted from the Global Burden of Disease 2019 (GBD-2019) website. Correlation tests are used to check the relationship between these indicators and the human development index.
The highest incidence rate of breast cancer in 2019 is related to the provinces of Gilan (29 per 100,000) and Tehran (28.55 per 100,000) and the highest rate of death from breast cancer is related to the provinces of Gilan (10.71 per 100,000). and Semnan (9.97 in 100,000). The results showed that there is a positive and significant correlation between DALY (r = 0.626, P < 0.0001), YLL (r = 0.611, P < 0.0001) and, YLD (r = 0.773, P < 0.0001) breast cancer with HDI index. There is a positive and significant correlation between the incidence (r = 0.794, P < 0.0001) and mortality (r = 0.503, P = 0.003) of breast cancer with the HDI index.
Considering that a positive correlation was observed between the incidence and burden of breast cancer and the human development index in the country, it is suggested to implement preventive measures such as public education programs to reduce the incidence and burden of breast cancer and the necessity of screening programs in areas with low human development index. It confirms the diagnosis of disease cases.
乳腺癌是全球女性最常见的癌症之一。本研究旨在探讨 2009 年至 2019 年期间伊朗乳腺癌的负担及其与人类发展指数（HDI）的关系。
本研究是 2009 年至 2019 年期间在伊朗进行的一项观察性研究。从全球疾病负担 2019 年（GBD-2019）网站提取了伊朗乳腺癌发病率、死亡率、残疾生命年（YLD）、生命损失年（YLL）和伤残调整生命年（DALY）的数据。相关性检验用于检查这些指标与人类发展指数之间的关系。
2019 年乳腺癌发病率最高的地区是吉兰省（29/10 万）和德黑兰（28.55/10 万），乳腺癌死亡率最高的地区是吉兰省（10.71/10 万）和塞姆南省（10 万）。结果表明，DALY（r=0.626，P<0.0001）、YLL（r=0.611，P<0.0001）和 YLD（r=0.773，P<0.0001）与 HDI 指数之间存在正相关和显著相关性癌症。乳腺癌发病率（r=0.794，P<0.0001）和死亡率（r=0.503，P=0.003）与 HDI 指数之间存在正相关和显著相关性。
考虑到该国乳腺癌的发病率和负担与人类发展指数之间存在正相关，建议实施公共教育计划等预防措施，以降低乳腺癌的发病率和负担，并在人类发展指数较低的地区开展筛查计划。确认疾病病例的诊断。
